Therefore, NSCLC patients with decreased TFPI-1 levels may be in risk for DVT and tumor metastasis, which indicates that TFPI-1 is useful to predict DVT and tumor metastasis at the time of diagnosis of NSCLC. The gene discussed is TFPI; the disease is non-small cell lung carcinoma.